The role of the Burnham Cancer Center Administration is to provide the administrative support and management for the Center to effectively pursue its mission of cancer research within the CCSG Guidelines. Because of the extraordinarily close integration of the Burnham Institute and the Cancer Center, the Institute provides all basic general administrative functions for the Cancer Center. This allows the Cancer Center Administration to focus on comprehensive management of the CCSG, and other Cancer Center-specific issues. The Cancer Center Administration also serves as a conduit to the Institute's administrative services, assuring the Center receives the needed quantity and quality of services to optimally support Cancer Center operations and comply with all relevant regulations. Key functions of the Cancer Center Administration include: Administrative support for Cancer Center Planning, management and evaluation Management of the CCSG budget, providing monitoring, oversight, financial analysis, and forecasting Coordination of Center Membership and member recruitment Coordination and documentation of meetings, including internal and external Center oversight groups Laboratory space management Management and oversight of the Shared Resources - both operational and budgetary Liaison to and oversight of Institute administrative services provided to the Cancer Center Assure adherence to all CCSG Guidelines Maintain Cancer Center records Preparation of CCSG-required summaries Communications with NCI on administrative matters, responding to inquiries, and compliance To carry out the Cancer Center Administration, CCSG funds are requested to support a portion of salary of two Associate Directors who provide these administrative services. The remainder of their effort is covered with Institutional funds. In addition, one institutionally funded Administrative Coordinator provides support for the Center Director and the two administrative Associate Directors.
The Cancer Center Administrafion provides central support for the Cancer Center Senior Leadership, Programs, Development, and Shared Resources. The Administrafion serves to oversee and assure the efficient and appropriate use of CCSG funds and the operafion of the Center within the CCSG Guidelines.
|Barile, Elisa; Marconi, Guya D; De, Surya K et al. (2017) hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents. ACS Chem Biol 12:444-455|
|Attali, Ilan; Tobelaim, William Sam; Persaud, Avinash et al. (2017) Ubiquitylation-dependent oligomerization regulates activity of Nedd4 ligases. EMBO J 36:425-440|
|Linares, Juan F; Cordes, Thekla; Duran, Angeles et al. (2017) ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma. Cell Metab 26:817-829.e6|
|Todoric, Jelena; Antonucci, Laura; Di Caro, Giuseppe et al. (2017) Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. Cancer Cell 32:824-839.e8|
|Scortegagna, Marzia; Berthon, Annabel; Settas, Nikolaos et al. (2017) The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. JCI Insight 2:|
|Jellusova, Julia; Cato, Matthew H; Apgar, John R et al. (2017) Gsk3 is a metabolic checkpoint regulator in B cells. Nat Immunol 18:303-312|
|Avellaneda Matteo, Diego; Grunseth, Adam J; Gonzalez, Eric R et al. (2017) Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency. J Biol Chem 292:7971-7983|
|Lee, Bongyong; Sahoo, Anupama; Marchica, John et al. (2017) The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules. Sci Adv 3:e1602505|
|McKeithan, Wesley L; Savchenko, Alex; Yu, Michael S et al. (2017) An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes. Front Physiol 8:766|
|Toome, Kadri; Willmore, Anne-Mari A; Paiste, Päärn et al. (2017) Ratiometric in vivo auditioning of targeted silver nanoparticles. Nanoscale 9:10094-10100|
Showing the most recent 10 out of 483 publications